n-vinyl-2-pyrrolidinone has been researched along with Pleural Effusion, Malignant in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YM; Perng, RP; Ting, CC; Tsai, WY; Whang-Peng, J; Yang, DM; Yang, WK | 1 |
| Ibarra-Perez, C; Kelly-Garcia, J; Roman-Berumen, JF | 1 |
| Morresi-Hauf, A; Welsch, U; Wöckel, W | 1 |
1 trial(s) available for n-vinyl-2-pyrrolidinone and Pleural Effusion, Malignant
| Article | Year |
|---|---|
Iodopovidone and bleomycin pleurodesis for effusions due to malignant epithelial neoplasms.
Topics: Acrylic Resins; Adult; Aged; Antibiotics, Antineoplastic; Bleomycin; Epithelium; Female; Humans; Iodine; Male; Middle Aged; Neoplasms; Pleural Effusion, Malignant; Pleurodesis; Povidone | 1997 |
2 other study(ies) available for n-vinyl-2-pyrrolidinone and Pleural Effusion, Malignant
| Article | Year |
|---|---|
Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients.
Topics: Adenocarcinoma; Cell Separation; Cells, Cultured; Centrifugation; Colloids; Contrast Media; Cytotoxicity, Immunologic; Diatrizoate; Ficoll; Humans; Immune Tolerance; Immunocompetence; Interleukin-10; Interleukin-12; Interleukin-2; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Lung Neoplasms; Lymphocyte Activation; Lymphocytes; Lymphocytes, Tumor-Infiltrating; Pleural Effusion, Malignant; Povidone; Recombinant Proteins; Silicon Dioxide; T-Lymphocytes, Helper-Inducer; Th1 Cells; Th2 Cells | 1997 |
[Polyvinylpyrrolidone deposits in the pleura].
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Foreign Bodies; Humans; Microscopy, Electron; Middle Aged; Pleura; Pleural Effusion, Malignant; Pleurodesis; Povidone | 1999 |